SCHEMBL13147666

SCHEMBL13147666

COc1ccsc1-c1cc(N)nc(-c2nc(C(F)(F)F)cs2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.35
MEN1 O00255 6/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
MAPT P10636 5/20 0.35
KDM4E B2RXH2 4/20 0.35
NPC1 O15118 4/20 0.35
ALDH1A1 P00352 3/20 0.35
RAB9A P51151 3/20 0.35
HTT P42858 2/20 0.35
IDH1 O75874 3/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
LMNA P02545 2/20 0.32
HPGD P15428 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP19A1 P11511 1/20 0.32
DCK P27707 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577588 0.87 PPARD (0.36) KMT2AMEN1SMN1; SMN2MAPTKDM4E
SCHEMBL13147670 0.85 KDM4E (0.36) KMT2AMEN1KDM4EALDH1A1HTT
SCHEMBL14706482 0.84 PPARD (0.33) KMT2AMEN1SMN1; SMN2MAPTKDM4E
SCHEMBL13147740 0.80 IDH1 (0.41) KMT2AKDM4EALDH1A1IDH1HSD17B10
SCHEMBL577242 0.80 PPARD (0.33) KMT2AMEN1SMN1; SMN2MAPTKDM4E
SCHEMBL13147741 0.79 IDH1 (0.37) KMT2AMEN1SMN1; SMN2MAPTKDM4E
SCHEMBL13147675 0.79 IDH1 (0.35) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL578438 0.78 MAPT (0.38) KMT2AMEN1SMN1; SMN2MAPTKDM4E
SCHEMBL13147662 0.78 IDH1 (0.36) KMT2ASMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL13147657 0.77 IDH1 (0.41) RAB9AIDH1CYP19A1CYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed